Efficient targeted gene delivery by a novel PAMAM/DNA dendriplex coated with hyaluronic acid

Nanomedicine

Volumn 9, Issue 18, 2014, Pages 2787-2801

  Urbiola, Koldo ^a   Sanmartín, Carmen ^a   Blanco Fernández, Laura ^a   De Ilarduya, Conchita Tros ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

gene therapy; gene transfer; hyaluronic acid hyaluronan; nanoparticle; nanotechnology; polyamidoamine dendrimer

Indexed keywords

DENDRIMER; EDETIC ACID; HERMES ANTIGEN; HYALURONIC ACID; LUCIFERASE; PLASMID DNA; POLYAMIDOAMINE; POLYETHYLENEIMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL LINE; CELL VIABILITY; CHEMICAL ANALYSIS; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOTOXICITY; DRUG COATING; FEMALE; GENE DELIVERY SYSTEM; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO GENE TRANSFER; IN VIVO STUDY; MCF 7 CELL LINE; MOUSE; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; REPORTER GENE; ZETA POTENTIAL;

EID: 84920096829     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.14.45     Document Type: Article

References (37)

1. Mintzer MA, Simanek EE. Nonviral vectors for gene delivery. Chem. Rev. 109(2), 259-302 (2009).
2. Tomalia DA, Baker H, Dewald J et al. New class of polymers: Starburst-dendritic macromolecules. Polymer J. 17(1), 15 (1985).
3. Mintzer MA, Grinstaff MW. Biomedical applications of dendrimers: A tutorial. Chem. Soc. Rev. 40(1), 173-190 (2011).
4. Duncan R, Izzo L. Dendrimer biocompatibility and toxicity. Adv. Drug. Deliv. Rev. 57(15), 2215-2237 (2005).
5. Lee CC, Mackay JA, Frechet JM, Szoka FC. Designing dendrimers for biological applications. Nat. Biotechnol. 23(12), 1517-1526 (2005).
6. Zhang Q, Chen S, Zhuo RX, Zhang XZ, Cheng SX. Self-Assembled terplexes for targeted gene delivery with improved transfection. Bioconjug. Chem. 21(11), 2086-2092 (2010).
7. Haensler J, Szoka FC. Polyamidoamine cascade polymers mediate efficient transfection of cells in culture. Bioconjug. Chem. 4(5), 372-379 (1993).
8. Kukowska-Latallo JF, Bielinska AU, Johnson J, Spindler R, Tomalia DA, Baker JR. Efficient transfer of genetic material into mammalian cells using Starburst polyamidoamine dendrimers. Proc. Natl Acad. Sci. USA 93(10), 4897-4902 (1996).
9. Underhill C. CD44, the hyaluronan receptor. J. Cell. Sci. 103, 293-298 (1992).
10. Naor D, Sionov RV, Ish-Shalom D. CD44: Structure, function, and association with the malignant process. Adv. Cancer Res. 71, 241-319 (1997).
11. Gvozdenovic A, Arlt MJ, Campanile C et al. Silencing of CD44 gene expression in human 143-B osteosarcoma cells promotes metastasis of intratibial tumors in SCID mice. PLoS ONE 8(4), e60329 (2013).
12. Qhattal HS, Liu X. Characterization of CD44-mediated cancer cell uptake and intracellular distribution of hyaluronan-grafted liposomes. Mol. Pharm. 8(4), 1233-1246 (2011).
13. Banerji S, Wright AJ, Noble M et al. Structures of the CD44-hyaluronan complex provide insight into a fundamental carbohydrate-protein interaction. Nat. Struct. Mol. Biol. 14(3), 234-239 (2007).
14. Bustin M, Reeves R. High-mobility-group chromosomal proteins: Architectural components that facilitate chromatin function. Prog. Nucleic Acid Res. Mol. Biol. 54, 35-100 (1996).
15. Ito T, Iida-Tanaka N, Koyama Y. Efficient in vivo gene transfection by stable DNA/PEI complexes coated by hyaluronic acid. J. Drug Target. 16(4), 276-281 (2008).
16. Peer D, Margalit R. Tumor-Targeted hyaluronan nanoliposomes increase the antitumor activity of liposomal doxorubicin in syngeneic and human xenograft mouse tumor models. Neoplasia 6(4), 343-353 (2004).
17. He Y, Cheng G, Xie L, Nie Y, He B, Gu Z. Polyethyleneimine/DNA polyplexes with reduction-sensitive hyaluronic acid derivatives shielding for targeted gene delivery. Biomaterials 34(4), 1235-1245 (2013).
18. Ito T, Iida-Tanaka N, Niidome T et al. Hyaluronic acid and its derivative as a multi-functional gene expression enhancer: Protection from non-specific interactions, adhesion to targeted cells, and transcriptional activation. J. Control. Release 112(3), 382-388 (2006).
19. Hornof M, De La Fuente M, Hallikainen M, Tammi RH, Urtti A. Low molecular weight hyaluronan shielding of DNA/PEI polyplexes facilitates CD44 receptor mediated uptake in human corneal epithelial cells. J. Gene Med. 10(1), 70-80 (2008).
20. Wang Y, Xu Z, Zhang R, Li W, Yang L, Hu Q. A facile approach to construct hyaluronic acid shielding polyplexes with improved stability and reduced cytotoxicity. Colloids Surf. B Biointerfaces 84(1), 259-266 (2011).
21. Jiang G, Park K, Kim J, Kim KS, Hahn SK. Target specific intracellular delivery of siRNA/PEI-HA complex by receptor mediated endocytosis. Mol. Pharm. 6(3), 727-737 (2009).
22. Han SE, Kang H, Shim GY et al. Cationic derivatives of biocompatible hyaluronic acids for delivery of siRNA and antisense oligonucleotides. J. Drug Target. 17(2), 123-132 (2009).
23. Yao J, Fan Y, Du R et al. Amphoteric hyaluronic acid derivative for targeting gene delivery. Biomaterials 31(35), 9357-9365 (2010).
24. Needham CJ, Williams AK, Chew SA, Kasper FK, Mikos AG. Engineering a polymeric gene delivery vector based on poly(ethylenimine) and hyaluronic acid. Biomacromolecules 13(5), 1429-1437 (2012).
25. Surace C, Arpicco S, Dufay-Wojcicki A et al. Lipoplexes targeting the CD44 hyaluronic acid receptor for efficient transfection of breast cancer cells. Mol. Pharm. 6(4), 1062-1073 (2009).
26. Han M, Lv Q, Tang XJ et al. Overcoming drug resistance of MCF-7/ADR cells by altering intracellular distribution of doxorubicin via MVP knockdown with a novel siRNA polyamidoamine-hyaluronic acid complex. J. Control. Release 163(2), 136-144 (2012).
27. Chen CJ, Zhao ZX, Wang JC et al. A comparative study of three ternary complexes prepared in different mixing orders of siRNA/redox-responsive hyperbranched poly(amido amine)/ hyaluronic acid. Int. J. Nanomedicine 7, 3837-3849 (2012).
28. Navarro G, Tros De Ilarduya C. Activated and non-Activated PAMAM dendrimers for gene delivery in vitro and in vivo. Nanomedicine 5(3), 287-297 (2009).
29. Navarro G, Maiwald G, Haase R et al. Low generation PAMAM dendrimer and CpG free plasmids allow targeted and extended transgene expression in tumors after systemic delivery. J. Control. Release 146(1), 99-105 (2010).
30. Mahato RI, Takakura Y, Hashida M. Nonviral vectors for in vivo gene delivery: Physicochemical and pharmacokinetic considerations. Crit. Rev. Ther. Drug Carrier Syst. 14(2), 133-172 (1997).
31. Mislick KA, Baldeschwieler JD. Evidence for the role of proteoglycans in cation-mediated gene transfer. Proc. Natl Acad. Sci. USA 93(22), 12349-12354 (1996).
32. Kurosaki T, Morishita T, Kodama Y et al. Nanoparticles electrostatically coated with folic acid for effective gene therapy. Mol. Pharm. 8(3), 913-919 (2011).
33. Arigita C, Zuidam NJ, Crommelin DJ, Hennink WE. Association and dissociation characteristics of polymer/ DNA complexes used for gene delivery. Pharm. Res. 16(10), 1534-1541 (1999).
34. Von Gersdorff K, Sanders NN, Vandenbroucke R, De Smedt SC, Wagner E, Ogris M. The internalization route resulting in successful gene expression depends on both cell line and polyethylenimine polyplex type. Mol. Ther. 14(5), 745-753 (2006).
35. Li J, He Y, Sun W et al. Hyaluronic acid-modified hydrothermally synthetised iron oxide nanoparticles for targeted tumor MR imaging. Biomaterials 35, 3666-3677 (2014).
36. Ganesh S, Iyer AK, Gattacceca F, Morrissey DV, Amiji MM. In vivo biodistribution of siRNA and cisplatin administered using CD44-Targeted hyaluronic acid nanoparticles. J. Control. Release 172, 699-706 (2013).
37. Toriyabe N, Hayashi Y, Hyodo M, Harashima H. Synthesis and evaluation of stearylated hyaluronic acid for the active delivery of liposomes to liver endothelial cells. Biol. Pharm. Bull. 34(7), 1084-1089 (2011).